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The K219T-Lamin mutation induces conduction
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Mutations in LMNA, which encodes the nuclear proteins Lamin A/C, can cause cardio-
myopathy and conduction disorders. Here, we employ induced pluripotent stem cells (iPSCs)
generated from human cells carrying heterozygous K219T mutation on LMNA to develop a
disease model. Cardiomyocytes differentiated from these iPSCs, and which thus carry K219T-
LMNA, have altered action potential, reduced peak sodium current and diminished conduction
velocity. Moreover, they have significantly downregulated Nav1.5 channel expression and
increased binding of Lamin A/C to the promoter of SCN5A, the channel’s gene. Coherently,
binding of the Polycomb Repressive Complex 2 (PRC2) protein SUZ12 and deposition of the
repressive histone mark H3K27me3 are increased at SCN5A. CRISPR/Cas9-mediated cor-
rection of the mutation re-establishes sodium current density and SCN5A expression. Thus,
K219T-LMNA cooperates with PRC2 in downregulating SCN5A, leading to decreased sodium
current density and slower conduction velocity. This mechanism may underlie the conduction
abnormalities associated with LMNA-cardiomyopathy.
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Cardiomyopathy (CMP) is the most prevalent phenotype oflaminopathies, a group of diseases caused by mutations ofthe nuclear lamina proteins Lamin A and C (Lamin A/C),
which are encoded by LMNA. Lamin A/C are main components
of the nuclear lamina, and play a key role in maintaining the
structural integrity of the nucleus and in processes such as DNA
replication, transcription and chromatin organization1–4. More
than 200 heterozygous mutations on LMNA are known to cause
over 20 phenotypes in which either tissues and organs are
selectively affected—mainly bone, cartilage, skeletal muscle, and
the heart—or multiple organ systems are involved, causing
accelerated ageing (progeria)5. Cardiac defects eventually occur in
all symptomatic patients, manifesting either as an isolated phe-
notype or in association with a variety of skeletal muscular dys-
trophies, such as Emery Dreifuss muscular dystrophy, limb girdle
muscular dystrophy, and lipodystrophies6.
At the clinical level, LMNA-dependent CMP (LMNA-CMP) is
characterized by chamber dilatation, typically preceded by con-
duction defects and arrhythmic events, which may occur before
any detectable dysfunction7,8. Notably, fatal arrhythmias and
consequential sudden cardiac death occur in almost 50% of
LMNA-CMP patients9,10. Although age at disease onset is vari-
able, almost all affected patients become symptomatic by the sixth
decade and eventually progress onto heart failure necessitating
transplantation11,12.
In vivo studies on Lmna knock-in and knock-out murine
models have been fundamental in elucidating the effects of Lamin
A/C deficiency or mutations on cardiac function. They reproduce
the main clinical features of the human disease (i.e., dilated CMP
and atrio-ventricular block), providing important pathophysio-
logical insights13–16. However, while murine models are necessary
for functional studies on whole heart, rodent and human cardiac
physiologies differ significantly. Thus, mechanisms specific to the
human species may be missed. Unfortunately, studies on human
cells carrying LMNA mutations have been mostly limited to
fibroblasts, skeletal muscle cells and adipocytes, while those on
isolated cardiomyocytes (CMs) are scarce17–19.
CMs differentiated from induced pluripotent stem cells
(iPSCs) have been used to understand the mechanisms and
pathophysiology of many cardiac diseases and provide a reliable
tool for drug screening applications20–22. To date, very few
studies investigating CMs derived from patient-specific iPSC
lines carrying a mutation in LMNA (i.e., the R225X nonsense
and R190W missense mutations) have been published: results
indicated an effect on cellular senescence and apoptosis
dependent on the ERK1/2 pathway in the presence of the
nonsense mutation;23,24 abnormal activation of ERK1/2 signal-
ing and sarcomeric disorganization were reported in iPSC-CMs
carrying the R190W mutation25. Nevertheless, our under-
standing of the pathophysiological mechanisms in LMNA-CMP
remains incomplete, particularly with regard to conduction
defects.
For the present study, we integrated functional and molecular
investigations on CMs generated through iPSC technology to
determine the effect of the K219T LMNA mutation26 on the
electrophysiological properties of CMs. CRISPR/Cas9-mediated
gene-editing and ex-vivo analyses on heart specimens from
patients with the K219T mutation were also employed. We
found that this mutation specifically affects expression of the
sodium channel Nav1.5 via an epigenetic mechanism involving
interplay with Polycomb Group proteins and targeting of the
expression of the gene encoding this channel, SCN5A. Thus, we
identify a cause–effect link between a Lamin A/C mutation,
altered Nav1.5 expression and CM action potential changes,
which might explain the arrhythmogenic conduction defects in
these patients.
Results
Generation of an iPSC-based model of LMNA-CMP. We gen-
erated a model of cardiac laminopathy from iPSCs obtained from
fibroblasts harvested from three members of a large family
affected by the disease. The family, previously identified by us to
carry the K219T mutation on LMNA26, presented with dilated
cardiomyopathy associated with arrhythmogenic conduction
disorders. Detailed clinical information is provided in Supple-
mentary Table 1, Supplementary Fig. 1, and Supplementary
Extended Methods. Control iPSC lines were generated from two
healthy family members not carrying the mutation.
Following characterization of pluripotent status and genomic
stability (Supplementary Figs. 2, 3), patient-derived and control
iPSC lines (two clones per individual) were differentiated towards
the cardiac lineage (iPSC-CMs) with a standard protocol27 that
reproducibly generates >80% pure CMs (Supplementary Fig. 4A).
iPSC-CMs had spontaneous depolarizations and contractions
(Fig. 1a, Supplementary Movies 1, 2), and expressed the cardiac-
specific marker α-sarcomeric actinin (Supplementary Fig. 4A, B),
which was, however, abnormally distributed in CMs differen-
tiated from K219T-LMNA-iPSC lines (K219T-CMs): the staining
was punctuated and fragmented, suggestive of the presence of
disorganized myofilament structures (Supplementary Fig. 4B).
This phenotype was observed in 50% of K219T-CMs, but in <15%
control cells (CNTR-CMs; Supplementary Fig. 4C). Furthermore,
measuring passive CM properties by patch clamp revealed a
higher membrane capacity in K219T-CMs, indicating increased
cell size (Supplementary Fig. 4D). Surprisingly, in contrast with
previous observations by us and others on primary cells and
mature adult CMs from affected patients5,26,28, morphological
analyses of K219T-CMs did not reveal any sign of the nuclear
defects typical of laminopathic cells, such as nuclear blebbing and
invagination (Supplementary Fig. 4E), characteristics which
probably develop in adult CMs after long-term stress.
Thus, CMs generated from K219T-LMNA-iPSCs recapitulate
some of the fundamental defects observed in LMNA-CMP,
including dilatation and sarcomeric disorganization, and provide
a suitable platform for investigating the molecular mechanisms
underlying the disease.
K219T-LMNA alters the action potential properties of CMs.
We then investigated how K219T-LMNA affects the functionality
of CMs through comprehensive electrophysiological analysis of
the action potential (AP) properties of iPSC-CMs with conven-
tional patch-clamp methods.
We found that maximal diastolic potential (MDP) and
maximal upstroke velocity (dV/dtmax), together with the related
AP properties peak voltage (overshoot) and AP amplitude (APA),
were significantly altered in K219T-CMs. Indeed, MDPs were
significantly more depolarized in K219T-CM vs. CNTR-CMs
(Fig. 1b—left panel, Supplementary Fig. 5). As a consequence of
the observed depolarized MDP values, 73% of the analysed
CNTR-CMs (33 cells out of 45) and 52% of K219T-CMs (24 out
of 46 cells) exhibited spontaneous APs (Fig. 1a), which are never
observed in healthy human adult ventricular CMs29.
While AP duration was not changed in spontaneously active
K219T-CMs, all the other analysed AP parameters—specifically
dV/dtmax, overshoot and APA—were significantly decreased in
K219T-CMs (Fig. 1c, d, Supplementary Table 2). In particular,
dV/dtmax, which reflects the peak Na+ current (INa) during the
upstroke30, was reduced by 36.1% in K219T-CMs. Of note, dV/
dtmax and its related AP properties (overshoot and APA) are a
function of the electrical excitability of a CM and depend on the
sarcolemmal fast voltage-dependent Na+ channel (Nav1.5)
repertoire and its functional expression31.
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Since changes in MDP influence Na+ channel availability, with
the majority of channels in their inactivated state being at a more
positive potential, we also studied the decreased excitability by
recording AP parameters in CMs in which the MDP was adjusted to
a physiological resting cardiac membrane potential range (i.e., ~
−80mV) by electrical injection of a constant hyperpolarizing current
—referred to here as evoked APs. This condition better resembles
that of human adult ventricular CMs32 and bypasses both the
inactivation of Na+ channels and mechanisms of spontaneous
membrane depolarization33. As expected, we found higher values of
dV/dtmax and APA in iPSC-derived CMs with evoked APs vs
spontaneously active CMs; again, AP properties related to excitability
were significantly decreased in such electrically conditioned K219T-
CMs (Fig. 1e, f, Supplementary Table 2, Supplementary Fig. 6).
Those data were confirmed when AP parameters were recorded
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characteristics21. These additional evaluations were included in
the first set of analyses to exclude potential underestimation of INa
due to contamination with pacemaker cells, which are more
depolarized and devoid of Nav1.5. Indeed, differentiation of iPSCs
into CMs is known to give rise to a mixed population of atrial-
like, ventricular-like, and pacemaker-like CMs, with the majority
presenting the ventricular phenotype:21,34 these different popula-
tions are typified by distinct AP parameters that reflect on AP
morphology and determine specific functional outcomes35. In
line with the results obtained in spontaneously active iPSC-CMs
and in those electrically adjusted to −82mV, AP parameters were
significantly decreased in working-like K219T-CMs vs. CNTR-
CMs (Supplementary Table 3), with a decrement in dV/dtmax of
29.8% (Supplementary Fig. 6).
Collectively, these results indicate that K219T is associated with
MDP depolarization and alterations in the electrical excitability
profile, which were linked to a decrease in the fast INa during the
upstroke.
K219T-CMs have reduced sodium current density. To corro-
borate the previous findings and quantify the effects of K219T on
INa density in iPSC-CMs, we measured peak INa density of fast
voltage-dependent sodium channels (Nav1.5) by whole-cell patch
clamp, using specific voltage protocols and external ionic solu-
tions. We found that average peak INa density was significantly
lower in K219T-CMs vs. CNTR-CMs (Fig. 2a), with a reduction of
41.3% at the membrane potential of −30 mV (Fig. 2b). Further-
more, no significant differences in voltage dependence of activa-
tion and inactivation parameters (half-maximal voltage [V1/2] and
slope factor [k]) were detected between the two (Fig. 2c, Sup-
plementary Table 4).
Of note, Nav1.5 currents and their voltage dependencies
measured in CNTR-CMs were in line with published values
obtained in control human iPSC-CMs36,37, further proving the
validity of our experimental setting and results.
Taken together, these results indicated a profound impairment
of INa in CMs carrying the K219T mutation, linked to the lower
dV/dtmax described above.
In addition, R190W—another heterozygous mutation on exon 3
of the gene, and also located in the rod domain of the protein
(Supplementary Fig. 7A)—affected INa in a similar manner to
K219T (Supplementary Fig. 7B–D), indicating that the phenotype
observed in K219T-CMs is not restricted to this specific mutation
and suggesting a more general mechanism through which missense
LMNA mutations may alter AP properties in affected CMs.
K219T-Lamin A/C blunts cardiac impulse propagation. Since
INa and MDP are both responsible for sustaining physiological
cardiac impulse propagation across the myocardium38, we next
determined the consequences of the biophysical changes descri-
bed above on cardiac conduction velocity. We thus measured
optical AP propagation in a confluent multi-cellular culture set-
ting consisting of 80-µm wide strands of electrically coupled
iPSC-CMs stained with the voltage-sensitive dye DI-8-ANEPPS
(Fig. 3a). K219T-CM strands failed to respond to increasing
electrical stimulation (1 and 2 Hz), resulting in a 2:1, 3:1 or
complete block of impulse propagation, possibly due to the
prolonged absolute refractory period secondary to the reduced INa
(Fig. 3b, c)39. Furthermore, conduction velocities (CVs) in
K219T-CM strands were significantly decreased (46.1%) (Fig. 3d),
further supporting the notion of an impairment of impulse pro-
pagation in laminopathic cells.
Ablation of conduction, induced by the selective blockage of
Nav1.5 with tetrodotoxin (TTX), confirmed that the conduction
defects observed in our cardiac laminopathy model are
specifically driven by Nav1.5 (Supplementary Fig. 8).
Reduced Na+ current is caused by downregulation of SCN5A.
Regulation of transcription and chromatin organization are
among the diverse roles attributed to Lamin A/C proteins18,40–44.
We therefore hypothesized that mutation of Lamin A/C could
interfere with the transcriptional program in K219T-CMs by
perturbing the correct expression of Nav1.5, leading to the con-
duction defects in our cellular model of laminopathy.
To prove this, we first analysed the expression of the Nav1.5
encoding gene, SCN5A, with RT-qPCR. We found that the level
of its transcript was significantly lower in K219T-CMs vs. CNTR-
CMs (Fig. 4a). Assessment of protein expression (through
Western blot and immunofluorescence analyses) confirmed
reduced expression of Nav1.5 in K219T-CMs (Fig. 4b–d).
Similarly, we found a reduced level of SCN5A mRNA also in
CMs carrying the R190W mutation (Supplementary Fig. 7E).
These findings support the hypothesis that reduction of Na+
currents in these cells is due to an effect on transcription by the
Lamin A/C mutation.
Epigenetic modulation of SCN5A expression by Lamin A/C. To
determine how the mutated Lamin A/C affects expression of
SCN5A, we performed chromatin immunoprecipitation (ChIP)
experiments to assess the occupancy of Lamin A/C on the gene’s
promoter. Binding of Lamin A/C to the SCN5A promoter was
increased in K219T-CMs vs. CNTR-CMs (Fig. 5a); no enrich-
ment was detected at the promoter of JUN (AP-1 Transcription
factor subunit), used as a control, demonstrating the specificity of
Lamin A/C immunoprecipitation. Instead Lamin A/C was equally
enriched in CNTR-CMs and K219T-CMs at the transcription
Fig. 1 Electrophysiological properties of single iPSC-CMs. a Examples of spontaneous action potentials recorded in CNTR-CMs and K219T-CMs (scale bar,
1 sec). b Dot plot with maximal diastolic potential (MDP) data recorded from CNTR-CMs and K219T-CMs, relative to all iPSC-CMs (quiescent and
spontaneously active cells: −61.3 ± 7.4 mV vs. −56.8 ± 9.6 mV—left panel) or to the spontaneously active cell population only (right panel), showing a
significant depolarization of K219T-CMs vs. CNTR-CMs in the first condition. CNTR-CMs: n= 45; K219T-CMs: n= 46. c, d Patch clamp analysis of AP
properties in spontaneously active iPSC-CMs. (CNTR: n= 33; K219T: n= 24). Dot plots for the main excitability features measured from spontaneous
action potentials: maximal upstroke velocity (dV/dtmax), overshoot (OV), action potential amplitude (APA) and action potential duration at 90%
repolarization (APD90) are shown in c. Representative spontaneous action potentials (left; scale bar, 100ms) and dV/dt (right; scale bar, 1 ms) in d (CNTR:
dV/dtmax= 18.4 ± 9.7 Vs−1, n= 33; overshoot= 22.6 ± 11.2 mV, n= 33; APA= 86.4 ± 15.2 mV, n= 33. K219T-CMs: dV/dtmax= 11.8 ± 9.2 V s−1, n= 24;
overshoot= 12.3 ± 11.6 mV, n= 24; APA= 74.2 ± 16.1 mV, n= 24). e, f Patch clamp analysis of AP properties in iPSC-CMs electrically adjusted to −82mV
(evoked APs-CNTR: n= 45; K219T: n= 46). Dot plots for the main excitability features measured from evoked action potentials: maximal upstroke velocity
(dV/dtmax), overshoot (OV), action potential amplitude (APA) and action potential duration at 90% repolarization (APD90) are shown in e. Representative
evoked action potentials (left; scale bar, 100ms) and dV/dt (right; scale bar, 2 ms) in f. Measurements highlighted with blue symbols in c and e were
obtained from action potentials shown in d and f. All values are reported as mean ± SD. *p < 0.05; **p < 0.005 (unpaired t-test). Data are relative to CMs
differentiated from 2 lines from each subjects (2 CNTR and 3 K219T-LMNA)
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start sites of SCN10A, DEFA3, and DEFA4 (Fig. 5a), known gene
targets of Lamin A/C18. This finding excluded the possibility of
an increased affinity of the antibody for K219T-Lamin A/C,
strengthening our conclusion that the mutated protein is involved
in regulating expression of SCN5A gene.
To further corroborate the specificity of Lamin A/C for SCN5A,
we determined the expression of other genes encoding proteins
playing key roles in cardiac conduction (i.e., CX40, CX43, TBX3
and TBX5) and assessed Lamin A/C binding at their promoters.
There were no significant changes in the expression of those
genes in K219T-CMs vs. CNTR-CMs, and no differences in
Lamin A/C enrichment at their promoters (Supplementary
Fig. 9A, B), further confirming the major contribution of SCN5A
regulation by Lamin A/C in determining the conduction
phenotype.
To correlate the presence of Lamin A/C with the epigenetic
landscape at the SCN5A locus in K219T-CMs, we performed a
ChIP analysis of two histone marks indicative of transcriptional
repression—tri-methylated lysine 27 on histone 3 (H3K27me3)
and tri-methylated lysine 9 on histone 3 (H3K9me3)—and one
mark of transcriptional activation—tri-methylated lysine 4 on
histone 3 (H3K4me3). The two repressive marks were enriched at
the locus in K219T-CMs (Fig. 5b, Supplementary Fig. 10A); in
contrast, H3K4me3 was enriched in CNTR-CMs (Supplementary
Fig. 10B). These results support the hypothesis that diminished
INa density in K219T-CMs is due to reduced SCN5A expression
which, in turn, is mediated by enrichment on its promoter of
Lamin A/C and the two repressive histone marks H3K9me3 and,
particularly, H3K27me3.
Nuclear lamins are also implicated in tethering chromatin to
the nuclear lamina45; these interactions occur through large
Lamin-Associated Domains (LADs) in chromatin and are
predominantly associated with transcriptional silencing42,46.
LADs are mostly cell-specific and may be distinguished into
a
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Fig. 2 Voltage-gated sodium currents in CMs from K219T-iPSC lines. a Left panel: examples of Na+ current (INa) traces recorded in CNTR- (top) and
K219T- (bottom) CMs (Scale bar, 2 ms, 50 pA/pF). Right panel: I-V curves constructed from average peak sodium current density as a function of voltage
command measured in CNTR-CMs and K219T-CMs, showing a significant reduction in the latter. CNTR-CMs: n= 23; K219T-CMs: n= 22. b INa density,
measured at −30 mV, in K219T-CMs (91.58 ± 30.69 pA/pF) relative to CNTR-CMs (156.12 ± 33.73 pA/pF), expressed as a percentage. c Voltage
dependences: steady state activation (CNTR-CMs: n= 23; K219T-CMs: n= 22)/inactivation curves (CNTR-CMs: n= 18; K219T-CMs: n= 17). All values
are reported as mean ± SD. **p < 0.005 (unpaired t-test). Data are relative to CMs differentiated from 2 independent lines from 2 CNTR and 3 K219T-
LMNA subjects
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constitutive (cLADs) and variable (vLADs) types, the latter
corresponding to LAD borders; these have been shown to be
enriched in H3K27me3 and to dynamically shift to and from the
nuclear periphery during development, determining distinct gene
expression outcomes44,47. Of note, impairment of this dynamic
reorganization of the genome has been shown during terminal
differentiation of skeletal myoblasts from Emery Dreifuss
Muscular Dystrophy patients, in human adipose stem cells and
during differentiation of iPSCs towards the endothelial lineage
in the presence of the lypodystrophy-causing R482W LMNA
mutation43,48,49. Here we found that, in CNTR-CMs, Lamin A/C
interacted with the SCN5A locus at early stages of cardiac
differentiation, but that binding was lost from day 12. In contrast,
in K219T-CMs such binding was maintained throughout
differentiation (Fig. 5c) and later in terminally differentiated
CMs (Fig. 5a). The finding is coherent with the hypothesis that
SCN5A may be included in a LAD that shifts from the nuclear
periphery towards the nuclear interior during differentiation, but
whole-genomic data from Lamin A/C ChIP-sequencing would be
necessary to prove that SCN5A is truly located in a LAD domain.
Nevertheless, this is consistent with ChIP-seq data on other cell
types18.
In addition, 3D-FISH (Fluorescence In-Situ Hybridization)47,50
mapping of the position of SCN5A within the nucleus revealed a
preferential positioning of the locus at the nuclear periphery in
K219T-CMs vs CNTR-CMs (Fig. 5d).
To provide evidence on the role played by Lamin A/C in vivo,
we used immunofluorescence microscopy and pathology tissue-
chromatin immunoprecipitation (PAT-ChIP) to assess SCN5A
gene regulation on paraffin-embedded sections of heart tissue
obtained from the patients carrying the K219T Lamin A/C
mutation. Coherently with our in vitro evidence, there was
reduced expression of Nav1.5 in adult CMs from K219T-LMNA
patients (Fig. 6a, b). This was associated with an increased
binding of Lamin A/C at the SCN5A promoter region (Fig. 6c).
These findings further support the hypothesis that K219T-
mutated Lamin A/C more strongly associates to the SCN5A
promoter, causing repression of its transcription.
K219T-Lamin A/C cooperates with PRC2 in repressing SCN5A.
To deepen understanding of the molecular mechanism by which
K219T-Lamin A/C affects transcriptional regulation of SCN5A,
we next determined if the gene’s expression was modulated by
cross-talk between Polycomb Group (PcG) proteins and Lamin
A/C. PcG proteins are epigenetic repressors that control the
expression of a large number of genes during development, dif-
ferentiation and disease. Interaction of PcG proteins with Lamin
A/C is required for correct compartmentalization and assembly of
the former40,51. Indeed, deficiency in Lamin A/C leads to dis-
assembly and dispersion of PcG proteins and is associated with an
impaired myogenic transcriptional program40,51.
Here, we focused on Polycomb Repressive Complex 2 (PRC2),
since it specifically catalyzes the methylation of lysine 27 on
histone 3 (H3K27me3), the repressive mark we found enriched at
the SCN5A promoter in K219T-CMs (see Fig. 5b). We thus
evaluated the binding of PcG proteins to the SCN5A promoter by
ChIP for Suz12, a component of PRC2. We found increased
binding of Suz12 in K219T-CMs (Fig. 7a), further supporting the
notion of cooperation between Lamin A/C and PcG proteins in
modulating transcriptional regulation in CMs.
In addition, immunoprecipitation (IP) experiments confirmed
this view and revealed that K219T-Lamin A/C is more bound to
Ezh2 (Enhancer of zeste homolog 2, the catalytic subunit of































































Fig. 3 Generation and propagation of optical action potentials in K219T-CMs. a Representative images of a monolayer of iPSC-CMs in geometrically
defined strands (80-µm wide, 1-cm long). Top: example of phase contrast image of a portion of a strand observed from the field of view; Bottom: same
strand after complete activation following electrical stimulation. Strands were stimulated from the left-hand side. b Stimulated optical action potentials in a
monolayer of CNTR- (top, black) and K219T- (bottom, red) CMs, showing that the latter fail to respond to a stimulation of 2 Hz. c Percentage of
propagated action potentials at 1 and 2 Hz stimulation. Black: CNTR-CMs; Red: K219T-CMs. d Conduction velocities recorded in cell strands consisting
of CNTR- (black bar) and K219T- (red bar) CMs (95.9 ± 48.5 mm s−1, n= 47 vs. 51.7 ± 34.7 mm s−1, n= 40). All values are reported as mean ± SD. **p <
0.005 (unpaired t-test). Data are relative to CMs differentiated from 2 independent lines from 2 CNTR and 3 K219T-LMNA subjects
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supports the hypothesis that the two proteins interact with higher
affinity in the presence of K219T.
The observation was corroborated by super-resolution
microscopy experiments, which revealed more-abundant co-
localization of the Lamin A/C and Suz12 in K219T-CMs vs.
CNTR-CMs (Fig. 7c). Of note, PRC2, alone or bound to Lamin
A/C, was differentially distributed in CNTR-CMs and K219T-
CMs, indicative of different protein dynamics in the two
conditions (Fig. 7d, Supplementary Fig. 11). In detail, a
proportion of the PRC2–LaminA/C complex was in closer
proximity to the nuclear periphery in K219T-CMs vs. CNTR-
CMs (Fig. 7d), a finding fitting well with results from 3D-FISH
experiments, which locate SCN5A preferentially at the nuclear
periphery in K219T-CMs, and sustains the notion that PRC2
and Lamin A/C cooperate to regulate SCN5A transcription by
simultaneously binding to its promoter at the nuclear periphery.
Moreover, a subpopulation of the complex significantly
relocated to the nuclear interior in K219T-CMs (Fig. 7d,
Supplementary Fig. 11), further supporting the notion that
global rearrangement of the two proteins is likely to alter global
transcription in the presence of LMNA mutations.
K219T-Lamin A/C transduction mimics the K219T-CM
phenotype. To further prove that mutant Lamin A/C exerts a
repressive activity on INa density by downregulating SCN5A
expression, we overexpressed K219T-LMNA in CMs derived
from the RUES2 human embryonic stem cell line and assessed
phenotype at the functional and molecular levels. To this end, we
generated a Lamin A/C-EGFP (enhanced green fluorescent pro-
tein) C-terminal fusion lentiviral construct carrying the K219T
mutation (Fig. 8a), and transduced RUES2-derived CMs. Trans-
duction was carried out at day 5–6 of cardiac differentiation
induction, a time-point at which Lamin A/C starts to become
expressed in these cells (Supplementary Fig. 12A). When
we compared Nav1.5 current density in GFPpos (expressing the
mutation) and GFPneg (wild-type) CMs, we found significantly
decreased INa in the former (at −30mV holding potential, 29.8%
decrease vs GFPneg; Fig. 8b, c), with no changes of the voltage
dependence of activation and inactivation parameters (half-
maximal voltage [V1/2] and slope factor [k]) between the two
conditions (Fig. 8d, Supplementary Table 4). Coherently,
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Fig. 4 Reduced sodium current density is dependent upon reduction of SCN5A expression. a RT-qPCR showing reduced expression of SCN5A gene in CMs
generated from K219T-LMNA-iPSCs vs those differentiated from CNTR lines. Data are represented relative to CNTR-CMs and normalized for expression of
the housekeeping genes 18S and HGPRT. Data are relative to CMs differentiated from 2 independent lines from 2 CNTR and 3 K219T-LMNA subjects.
b Left: Representative Western blot showing reduced Nav1.5 channel expression in K219T-CMs. Data are representative of one cell line per subject. Right:
Nav1.5 expression quantification in CNTR-CMs and K219T-CMs, calculated as densitometric Nav1.5 /β-actin ratio (the diagram represents the mean of
three independent experiments). c Representative immunofluorescence images for Nav1.5 (green) and α-sarcomeric actinin (red) in CNTR-CMs and
K219T-CMs; nuclei are stained with DAPI (Scale bars: 13 μm). A decrease in the expression of Nav1.5 in K219T-CMs vs. CNTR-CMs is evident. All values
are reported as mean ± SD. *p < 0.05 (unpaired t-test)
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By contrast, overexpression of either an empty GFP vector or a
vector encoding wild-type LMNA did not produce any effect on
Nav1.5 current density in RUES2-CMs (Supplementary Fig. 12,
Supplementary Table 4), further indicating that the observed
phenotype is causally linked to K219T on LMNA.
SCN5A overexpression rescues the functionality of LMNA-
CMs. To corroborate the hypothesis that the effect on INa is
directly mediated by downregulation of SCN5A, we overexpressed
C-terminus GFP-tagged wild-type SCN5A in LMNA-CMs car-
rying either K219T or R190W (Supplementary Fig. 13A), and
measured INa density by patch-clamp. We found that over-
expression of SCN5A in the presence of either of the two muta-
tions was sufficient to significantly increase INa density to a level
that was even higher than that in controls (Supplementary
Fig. 13B–D, Supplementary Table 4). Of note, Nav1.5-dependent
AP properties were also restored by SCN5A overexpression
(Supplementary Fig. 13E, Supplementary Table 5).
K219T correction rescues functional and molecular defects. To
unequivocally establish the direct link between the mutation and
the phenotype described above, we generated isogenic lines in
which the point mutation was specifically corrected (here referred
to as K219T-corrected), using a CRISPR-Cas9-mediated strategy
(Fig. 9a, b and Supplementary Fig. 14)52,53.
Comparative functional and molecular analyses of CMs
differentiated from K219T-corrected LMNA-iPSCs demonstrated
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Fig. 5 Epigenetic modulation of SCN5A gene expression. a, b ChIP analyses in CNTR-CMs and K219T-CMs with antibodies against Lamin A/C (a) and
H3K27me3 (b) targeting the SCN5A genomic region. Data are presented as a percentage of input chromatin precipitated and relative to 2 independent iPSC
clones from each subject. ChIP for Lamin A/C, indicating increased binding of Lamin A/C to the promoter region of the SCN5A gene in K219T-CMs; no
enrichment was detectable for JUN, used as a negative control region for the ChIP experiment; SCN10A, DEFA3, and DEFA4 were used as positive control
regions for the ChIP experiments, and they show comparable enrichment of Lamin A/C in CNTR-CMs and K219T-CMs (a). ChIP for the histone
modification H3K27me3, showing an enrichment of the repressive histone mark at the SCN5A gene promoter in K219T-CMs, supporting the reduced
expression of the gene detected in these cells; NEURO D was used as positive control region for the antibody (b). c ChIP against Lamin A/C, showing the
dynamics of Lamin A/C enrichment at the transcription start site (TSS) of SCN5A during cardiac differentiation (from days 0 to 12). The graph is relative to
one representative experiment (out of three). For this analysis, two-way ANOVA was used for the statistic test. **p < 0.01. d 3D-FISH for Lamin A/C
(green) and SCN5A (magenta) conducted with an antibody and a DNA probe, respectively. Left: representative images of nuclei from CNTR and K219T-CM
preparations (Scale bar: 9 μm). Magnified box shows the colocalization of the SCN5A probe at the nuclear lamina. Right: Analysis of the distance from the
nuclear lamina, showing preferential localization of the SCN5A probe (magenta) at the nuclear periphery in K219T-CMs vs. CNTR. Quantification was
carried out using a specific plug-in of the ImageJ software (CNTR-CMs: n= 72 cells; K219T-CMs: n= 82 cells; p < 0.0001). All values are reported as
means ± SD, if not differently specified. *p < 0.05; **p < 0.01, ns, not significant (unpaired t-test)
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and SCN5A expression to levels indistinguishable from those in
CNTR-CMs (Fig. 9c, d and Supplementary Table 4). Of note,
restoration of functional and molecular phenotypes was coupled
with decreased binding of Lamin A/C to the SCN5A promoter
(Fig. 9e), strongly supporting the hypothesis that dysregulation of
SCN5A and the consequential effect on INa is caused by the
mutation.
Taken together, these findings support a mechanistic model in
which mutated Lamin A/C perturbs SCN5A expression by
favouring the binding of PRC2 to its promoter, leading to
decreased peak INa and slower conduction velocity (Fig. 10).
Discussion
Understanding the molecular mechanisms underlying the elec-
trophysiological defects in LMNA-CMP is essential for improving
current therapeutic decisions. Patients who develop left ven-
tricular dysfunctions are currently treated with the standard
medical therapy for chronic heart failure, typically β-blockers and
inhibitors of the renin-angiotensin system, which are usually not
sufficient to prevent heart transplantation. Moreover, most
patients eventually require a pacemaker or implantable cardio-
verter defibrillator to prevent fatal arrhythmias.
For this study, we developed a patient-specific model of
cardiac laminopathy to determine how the heterozygous K219T
mutation on Lamin A/C contributes to the pathogenesis of the
clinical phenotypes associated to LMNA-CMP. Through com-
prehensive electrophysiological characterization of mutant
iPSC-derived CMs, we identified a series of consequential
functional defects affecting excitability and cardiac impulse
propagation that were caused by Lamin A/C-driven repression
of SCN5A expression, leading to reduced peak Nav1.5 density.
The major electrical phenotype that emerged consisted in a
reduced dV/dtmax, which we found to be linked to a profound
impairment of INa density. Importantly, the decreased cellular
excitability seen in LMNA-CMs is coherent with the different
AP characteristics and the biophysical parameters of all ana-
lysed cell populations (i.e., spontaneously active, electrically
adjusted and working-like iPSC-CMs), further validating the
use of this cellular model to study Nav1.5 current and con-
duction in LMNA-CMP.
While previous studies in other cellular systems have already
linked Lamin A/C mutations to Nav1.5 regulation, results have
been contradictory. Indeed, Liu and colleagues reported that
R644C and R190W exerted an inhibitory effect on Nav1.5 when
overexpressed in HEK293T cells54; a more recent study carried
out on ventricular CMs from homozygousN195K/N195K mice
produced opposite results, with increased peak INa and pro-
longation of AP duration55. Our findings clarify these dis-
crepancies and provide evidence for the phenotype in a relevant
human pathophysiological context, namely CMs derived from an
iPSC-based model of laminopathy.
It is well established that the density of voltage-gated Na+
current and inactivation of Na+ channels at depolarized MDPs
are at the basis of CM excitability and are a major determinant of
impulse propagation across the myocardium38. Many mutations
on SCN5A affecting expression or function of the Nav1.5 channel
have been found in patients with various forms of inherited
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Fig. 6 Lamin A/C-mediated reduction of Nav1.5 expression is confirmed in heart sections. a Immunostaining of paraffin-embedded heart sections from
patients carrying the K219T mutation on Lamin A/C (bottom panels) and from two control subjects (top panels) targeting the Nav1.5 sodium channel (red);
nuclei were stained with DAPI (scale bars: 10 μm). b Histogram showing the quantification of the red fluorescent signal shown in a, corresponding to the
Nav1.5 protein, confirming reduced expression also in K219T-LMNA patient hearts. (a.u. is for arbitrary units). Data are relative to heart sections from three
healthy controls (n= 11) and four mutant samples (n= 12). c PAT-ChIP analysis of heart sections from patients carrying the K219T mutation on LMNA (red
bar) and from two control subjects (black bar), showing increased binding of Lamin A/C at the SCN5A promoter region in K219T-CMs. Chromatin was
immunoprecipitated with an antibody against Lamin A/C and the resulting DNA was analysed by realtime PCR and presented as a percentage of input
chromatin precipitated for the indicated region. All values are reported as means ± SD. *p < 0.05; ***p < 0.0001 (unpaired t-test)
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arrhythmias;56 moreover, conduction defects and sudden death
also represent phenotypic hallmarks of LMNA-CMP4. These
notions strongly support a pathogenic role for downregulated Na+
channel expression in the onset of conduction disturbances seen
in K219T-CMs.
Along this line, conduction velocities (CVs) were significantly
decreased in confluent strands of K219T-CMs. As expected, most
likely because of the fetal-like maturation stage of CMs differ-
entiated from iPSCs34, CVs in CNTR multicellular strands
(~100 mm/s) were found to be slower than the physiological CVs
of neonatal CMs cultured on the same strands (~450 mm/s) or on
anisotropic intact myocardial tissue (~600 mm/s); nonetheless,
CVs recorded in our experiments were faster than those reported
by others in multicellular preparations of stem cell-derived CMs
(~50 mm/s)33,57. These differences are most likely due to different
cellular excitabilities, the particular electrical coupling among































































































Fig. 7 Lamin A/C–PRC2 interplay in the regulation of SCN5A transcription. a ChIP against Suz12, showing enrichment at the SCN5A promoter region in
K219T-CMs. No significant differences were detectable at the NEURO D promoter, used as positive control for the antibody. Data are presented as
percentage of input chromatin precipitated and relative to 2 independent iPSC lines per subject. (**p < 0.01, unpaired t-test). b Co-immunoprecipitation
(co-IP) of LaminA/C and Ezh2 (PRC2 subunit) in CNTR-CMs and K219T-CMs, showing a higher binding affinity of mutant LaminA/C for Ezh2. An
unrelated IgG antibody was used as negative control. One representative (out of three) experiment is shown. c 3D-STED super-resolution microscopy for
Lamin A/C and Suz12. Left: representative image of a nucleus stained for the two proteins. The inset shows co-localization of the two proteins (yellow
spots). Right: bar graph indicating the quantification of voxels of colocalization and showing higher levels of interaction in K219T-CMs vs. CNTR-CMs. (n=
16 cells for each condition). (*p < 0.05, unpaired t-test). d Distribution profile of the PRC2–Lamin A/C colocalization channel from 3D-STED microscopy
acquisitions. For the analysis, the distance transformation function of Imaris software was applied to the z-stack images. Left: Strategy to determine the
distance of the PRC2–Lamin A/C colocalization signal from the nuclear periphery. Top left: representative images of CNTR-CM and K219T-CM nuclei
(scale bar 2 μm). Gray spots indicate Lamin A/C fluorescent signal: this was selected as the outside ring and served as the nuclear edge. The colored bar is
indicative of the relative position of the spots to the nuclear edge: farthest positions in violet, closest in red. Bottom left: strategy of data representation:
distances were scored into three zones: (1) periphery (from 0 to 2.15 μm, white); (2) middle (from 2.15 to 4.3 μm, light gray); and (3) central zone (from
4.3 to 6.45 μm, dark gray). The distance of every single colocalization spot was calculated from the nuclear edge. Right: box plot graphs representing
PRC2–Lamin A/C distribution in the three selected zones. For each box plot, bottom and top of the boxes respectively indicate the lower and upper
quartiles of the data set and whiskers represent the highest and the lowest values. Center line is the median value. Values are referred to median ± SD (n=
5 cells per condition, obtained from 5 independent iPSC clones). (***p < 0.0001; **p < 0.01, two-way ANOVA)
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Impulse propagation across the myocardium depends not only
on CM excitability but is also determined by intercellular
conductance38,58; previous studies have linked LMNA-dependent
conduction defects to misexpression or mislocalization of Con-
nexin-43, a gap junctional protein that, in the heart, is localized at
the intercalated disks (end-to-end coupling) of CMs and is critical
for establishing intercellular conductance and driving impulse
propagation14,38,58,59. Even though we did not observe altered
Connexin-43 expression in our model, we cannot exclude the
possibility that reduced gap junctional coupling due to mis-
localization or internalization of the connexons may be involved
in determining the observed conduction defects. In support of
this assumption, we found that the slowing of CVs in K219T-
CMs was more profound than the reductions in dV/dtmax and INa
density in single-cell preparations. The stronger effect on CV than
on excitability parameters may be supported by an additive effect
of the two impulse propagation pathways (excitability and
intercellular conductance).
At the molecular level, we found an epigenetically-mediated
regulatory effect on SCN5A that affected the expression of the
Nav1.5 channel, leading to diminished INa density and impaired
impulse propagation. Besides a role in maintaining the structural
stability of the nucleus, Lamin A/C may have key regulatory roles
on gene transcription, either by direct interaction with DNA and
chromatin or through the binding to chromatin complexes or



















































































































Fig. 8 K219T-LMNA overexpression in RUES2-CMs reproduces phenotypes of K219T-CMs. a Lentiviral vector expressing the C-terminal GFP-tagged
K219T-Lamin A/C used for lentiviral particle production. b Analysis of sodium current (INa) densities in CMs differentiated from the human embryonic
stem cell line RUES2 and transduced with lentiviral particles expressing K219T-LaminA/C-GFP. Left column: examples of INa traces recorded in GFPneg
(top) and GFPpos CMs (bottom) (Scale bar, 2 ms, 50 pA/pF). Right panel: I-V curves constructed from average peak sodium current density as a function
of voltage command measured in GFPneg and GFPpos CMs. (GFPneg: n= 14; GFPpos: n= 21), showing significant Na+ current reductions in GFPpos cells.
c INa density, measured at −30 mV, in GFPpos (115.20 ± 43.35 pA/pF) vs. GFPneg (164.02 ± 43.18 pA/pF) CMs, expressed as a percentage. d Voltage
dependences: steady state activation (GFPneg: n= 14; GFPpos: n= 21)/inactivation (GFPneg: n= 11; GFPpos: n= 17) curves. e RT-qPCR comparing SCN5A
expression in GFPneg and GFPpos CMs isolated through FACS sorting. Data are represented relative to GFPneg samples and normalized to expression of
HGPRT and 18S housekeeping genes. Top: gating strategy and cell populations selected for the sorting are shown (sequential sorting strategy is provided in
the Supplementary Fig. 15). All values are reported as mean ± SD. *p < 0.05; **p < 0.005 (unpaired t-test)
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09929-w ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2267 | https://doi.org/10.1038/s41467-019-09929-w |www.nature.com/naturecommunications 11
occurs through large chromatin domains and in spatially restricted
regions on gene promoters, modulating gene expression18,41.
LMNA missense mutants have been found aberrantly associated
with specific portions of the genome, leading to transcriptional
defects, rearrangement of LADs and Lamin–chromatin associations
occurring at the nuclear interior43,62. It was therefore suggested that
changes in gene expression observed in cells from patients carrying
different types of Lamin A/C mutation (i.e., progeroid disorder,
lipodystrophies, and muscle dystrophy) were linked to gain/loss of
LADs, affecting genome architecture43,48,49,62,63. Even though
genome-wide investigations are necessary to identify lamin asso-
ciated domains and firmly establish their remodeling, our findings
well suit this regulatory circuit, providing a new piece of evidence
for Lamin A/C-dependent modulation of the expression of a key
gene in cardiac electrophysiology, SCN5A, as a determinant of the
disease.
In the mechanism we propose here, mutant Lamin A/C pro-
teins form a repressive complex with PRC2, which binds to the
SCN5A promoter and catalyzes the deposition of H3K27me3. In
this conformation, SCN5A is preferentially located at the nuclear
periphery. This further contributes to a repressive environment,
resulting in the downregulation of targeted-gene transcription
and leading to the diminished INa and impaired propagation
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ChIP and 3D-FISH experiments demonstrated selective and
dynamic binding of Lamin A/C to the SCN5A promoter in CMs
and throughout cardiac differentiation. However, we cannot
exclude that additional layers of chromatin regulation may be
involved. Indeed, since the nuclear lamina operates as a docking
platform for the binding of transcription factors and proteins
involved in transcriptional regulation, it is possible that other
factors (e.g., lamin-binding proteins, other chromatin regulators,
lncRNAs) may further regulate SCN5A expression.
Results from super-resolution STED microscopy further sup-
port the view that a regulatory circuit involving Lamin A/C and
PRC2 is acting on SCN5A at the nuclear periphery, indicating a
more abundant peripheral distribution of PRC2, by itself or bound
to Lamin A/C, in K219T-CMs. More generally, the distribution
profiles of the PRC2–Lamin A/C complex indicated that dynamics
significantly differ in wild-type and K219T CMs and distinguish
two conditions, one in which PRC2–Lamin A/C is closer to the
nuclear periphery and another in which there is a tendency to
relocate towards the interior. These findings are consistent with
the previously described link between Lamin A/C and the intra-
nuclear localization of PcG proteins and with their nuclear com-
partmentalization reported in cells lacking Lamin A/C51. The
concept that PRC2 and Lamin A/C may interact also at the
nuclear periphery is instead novel; although further investigations
are required, it is possible that the higher affinity of Lamin A/C for
PRC2 in the presence of the mutation results in persistent binding
of the two proteins together regardless of nuclear localization, and
that, in this form, they relocate through the nucleus to exert their
repressive effect. In addition, results from 3D-STED are also
indicative of different dynamics for mutant Lamin A/C and the
wild-type protein; this is in agreement with a recent study
describing the different dynamics of diverse mutated LMNAs64.
Fig. 9 Correction of K219T mutation rescues Na+ current phenotype and SCN5A expression. a Gene editing strategy used for the correction of the
mutation. b Representative electropherograms from DNA sequencing of exon 4 of the LMNA gene showing the correction of the alanine-to-cytosine
transversion at position 656 (c.656A<C) in the generated isogenic K219T-corrected iPSC lines (the reverse sequence is shown in the figure; the T<C
mutation is indicated by the arrow). The nucleotide mutation corresponds to the amino acid change p.K219T. The electropherogram from the parental
K219T-LMNA iPSC line is shown on the top panel as reference. c Left panel: examples of Na+ current (INa) traces recorded in CNTR- (top), K219T-
corrected (top) and K219T- (bottom) CMs (Scale bar, 2 ms, 50 pA/pF). Right panel: I-V curves constructed from average peak sodium current density as a
function of voltage command measured in the three conditions described above (CNTR: n= 23; K219T-corrected: n= 14; K219T: n= 22), showing
significant sodium current increases in K219T-corrected cells with respect to the parental mutant CMs. *adj.p < 0.05; **adj.p < 0.005 (two-way ANOVA).
d INa density, measured at −30 mV, in K219T-corrected CMs (176.94 ± 61.05 pA/pF) relative to K219T-CMs (91.58 ± 30.69 pA/pF) and CNTR-CMs
(156.12 ± 33.73 pA/pF) expressed as a percentage. e Voltage dependences: steady state activation (CNTR: n= 23; K219T-corrected: n= 14; K219T: n=
22)/inactivation (CNTR: n= 18; K219T-corrected: n= 12; K219T: n= 17) curves. f RT-qPCR showing that SCN5A gene expression is restored to control
levels in CMs generated from K219T-corrected-iPSCs. Data are represented relative to CNTR-CMs and normalized to expression of the housekeeping
genes 18S and HGPRT. g ChIP against Lamin A/C, showing loss of Lamin A/C binding at the SCN5A promoter region in K219T-corrected CMs vs mutant
K219T-CMs. Levels of Lamin A/C binding are instead indistinguishable from those detected in CMs differentiated from control cells. All values are reported





























Fig. 10 Proposed pathogenic mechanism of action of K219T-Lamin A/C in CMs. Left: healthy CMs. The SCN5A genomic region is localized in the nuclear
interior and actively transcribed; the Nav1.5 sodium channel density at the plasma membrane is sufficient to assure proper impulse propagation. Right:
Laminopathic CMs. Mutant Lamin A/C and PRC2 bind each other with high affinity and are enriched at the SCN5A promoter region, where the H3K27me3
(catalyzed by PRC2) and H3K9me3 repressive histone marks are also present. In this repressive environment, this genomic region is preferentially
sequestered at the nuclear periphery. As a result, SCN5A gene transcription is repressed, leading to reduced expression of the Nav1.5 sodium channel at the
plasma membrane, which, in turn, has an effect on reducing conduction velocity. This regulatory mechanism may be at the basis of the onset of the
conduction defects in patients with LMNA-CMP
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As a result of this global rearrangement, an effect on other
disease-relevant genes cannot be ruled out: transcriptional
reprogramming is likely to occur at a global level in differ-
entiating cardiac progenitors and CMs in the presence of mutated
Lamin A/C, leading to misregulation of genes involved in other
disease-relevant processes, such as contractility and cell
metabolism.
Besides this speculative view, our findings improve the
understanding of the pathogenesis of LMNA-CMP-related con-
duction defects and indicate a new pharmacological target.
Indeed, it is conceivable that clinically relevant results could be
had by either selectively activating the Nav1.5 channel through
specific modulators or inducing SCN5A expression (e.g., with
epigenetic drugs or nucleic acid mimics). Normalization of the
electrophysiological phenotype of mutated CMs through over-
expression of SCN5A together with the evidence that this gene is
positively modulated in isogenic K219T-corrected CMs point to
SCN5A as a potential gene-therapy target for LMNA-CMP.
In conclusion, we describe a new pathogenic mechanism for
the conduction defects associated with LMNA-CMPs, dependent
upon transcriptional changes driven by mutant Lamin A/C.
Whether the effect on the SCN5A is selective for certain muta-
tions affecting specific protein domains or is more broadly linked
to altered Lamin A/C conformation is still unclear and needs
further investigation.
Methods
iPSC lines generation and maintenance. iPSCs were generated from skin fibro-
blasts of three LMNA patients carrying the K219T mutation and two healthy
family members (without the mutation) using the STEMCCA polycistronic lenti-
viral vector65. Reprogrammed cells were selected by their morphology and tested
for their actual pluripotency21,66. Details on generation, characterization and
maintenance of the lines are provided in the Supplementary Extended Methods.
Generation of isogenic control iPSC lines. The heterozygous K129T mutation in
the LMNA gene was corrected back to the wild-type allele using a CRISPR/Cas9-
facilitated gene editing strategy based on a previously described method53,67,68.
The results described were obtained from line LMNA#1_2. Briefly, we
developed a two-step approach to change a single nucleotide in the absence of any
other genetic “scarring” (Fig. 8a and Supplementary Fig. 14A). First, we corrected
the mutation by homozygous insertion of a plasmid-based targeting cassette
carrying the wild-type sequence. This was obtained via homologous directed repair
followed by positive selection of gene-targeted clones based on a puromycin
resistance gene carried within by a piggyBac element. Secondly, we excised such
piggyBac cassette using transposase, leaving behind only a “TTAA” remnant
sequence. For this, corrected clones were enriched by a negative drug selection
strategy based on the human herpes simplex virus thymidine kinase gene also
carried by the piggBac. After each gene-targeting step, multiple clonal lines were
isolated and genotyped using a combination of genomic PCR assays. Uncropped
gels are provided in the Source Data file. Positive clones were further characterized
by targeted Sanger sequencing and karyotyped to confirm their genomic stability.
A more detailed description of this procedure is provided in the Extended
Methods of the Supplementary Information.
Cardiac differentiation. Differentiation into CMs was achieved using a
chemically-defined serum free protocol, which is based on Wnt pathway mod-
ulation in RPMI medium27,66. In brief, 95–100% confluent iPSCs were induced
with the Wnt activator CHIR99021 for 24 h and then, at day 3, exposed to IWR-1,
which inhibits the Wnt pathway, for 48 h. At day 10 of induction, medium is
supplemented with insulin. Spontaneous contracting activity usually appears
around day 8–10 of the differentiation process. Efficiency of the differentiation was
determined for all lines through the detection of the cardiac-specific marker α-
sarcomeric actinin by FACS. CMs were used for the experiments 20–25 days after
contraction started. Data presented are average of values obtained in CMs from 2
CNTR and 3 LMNA subjects; two iPSC lines per subject were used.
Electrophysiological analyses. Maximal diastolic potential (MDP), action
potential (AP) properties, and whole-cell Na+ current (INa) recordings were per-
formed in low-density cell cultures using a Multiclamp 700B patch-clamp amplifier
(Molecular Devices) and analysed with dedicated software (ClampFit 9.2). Whole
cell currents were normalized to cell capacitance and are reported as pA/pF. Single
iPSC-CMs were identified on the basis of their typical morphology21. Sponta-
neously active iPSC-CMs and iPSC-CMs in which the MDP was adjusted to
physiological resting cardiac membrane potentials by a constant hyperpolarizing
current injection were selected for measurement of AP characteristics.
Impulse propagation characteristics along 80-μm wide strand preparations were
assessed optically by a fast resolution camera (Ultima, Scimedia, USA).
Preparations were surperfused at 36 °C using the voltage-sensitive dye di-8-
ANEPPS. Conduction velocity was computed by linear regression of activation
times recorded along the preparation. Optical action potential propagation derived
from two strands was acquired for each field of view at 1 KHz sample resolution for
4 s recording. Magnification 10×, n.a. 0.5. n= 47 for CTRL-CMs, n= 40 for
K219T-CMs.
In all electrophysiological experiments, preparations were superfused at 1.5 ml
min−1 with HBSS containing 10 mmol l−1 of HEPES (pH 7.40) (Sigma Aldrich)
(pH 7.40). For INa recordings, a low Na+ solution was used that contained (in
mmol l−1): NaCl 70, CaCl2 1.8, CsCl 90, MgCl2 1.2, glucose 10, HEPES 10, and
nifedipine 0.001 (pH 7.4 with CsOH).
Protein analyses. Protein expression was analysed by Western blotting and
immunofluorescence. For the Western blotting, 30 μg of lysate was used. Primary
antibodies (Nav1.5 1:1000, anti-rabbit Cell Signaling D9J7S, β-actin 1:2000, anti-
goat Santa Cruz sc1615) were incubated overnight. For detection, HRP-conjugated
secondary antibodies and the Millipore Chemiluminescent HRP substrate kit were
used. Co-IP experiments were performed as previously51. Detailed protocol is
available in the Supplementary Methods. Uncropped blots from Western Blot
experiments are provided in the Source Data File.
For immunofluorescence, iPSC-CMs were fixed in 4% paraformaldehyde,
blocked with 3% serum and permeabilized with 0.1% Triton. Stainings were
performed using the following antibodies: anti-Nav1.5 channel protein (Alomone
#ASC005), anti-α-sarcomeric actinin protein (Abcam EA-53- ab9465), anti-Lamin
A/C (Santa Cruz Biotechnologies, N18 sc6215). For detection, we used Alexa-Fluor
488-conjugated and 555-conjugated secondary antibodies (Molecular Probes from
Thermo Scientific) raised in the appropriate species for the experiments. Images
were acquired on an FV1000 confocal laser-scanning microscope (Olympus) and
analysed using ImageJ software.
Binding of Lamin A/C and Suz12 was assessed by STimulated Emission
Depletion (STED) super-resolution microscopy. Cells were incubated overnight at
+4 °C with the primary antibodies against Lamin A/C (anti-mouse, from Santa
Cruz 7292-X, 1:250) and Suz12 (anti-rabbit, from Cell Signaling #3737, 1:250). For
detection, we used Abberior STAR RED-conjugated and STAR 580-conjugated
secondary antibodies. Images were acquired on a Leica TCS SP8 STED 3×
microscope and analysed using Imaris software. PRC2-Lamin A/C distribution
profiles ware determined using the “Distance transformation” Xtension of Imaris
Bitplane. Details of all experimental procedures and analyses are available in the
Extended Methods of the Supplementary Information.
Gene expression. Gene expression studies were performed on cDNA synthesized
from total RNA using SuperScript Vilo cDNA synthesis kit (ThermoFischer Sci-
entific). Comparative gene expression was determined by realtime PCR using Sybr
Green (ThermoFisher Scientific) and specific primers. A list of the primers used for
the experiments is provided in the Supplementary Information files (Supplemen-
tary Table 6). The relative expression was calculated as 2-ΔΔCt using the com-
parative Ct method and 18S or HGPRT as housekeeping control as detailed in the
respective figure legends.
Chromatin Immunoprecipitation. Two wells (of a 12-well plate) of confluent CMs
were fixed in 1% formaldehyde for 10 min and then quenched with 0.125 M of
glycine for 5 min. Chromatin was sonicated with Bioruptor Diagenode Sonicator
and immunoprecipitated overnight at 4 °C with 4 μg of Lamin A/C antibody (anti
Lamin A/C (636), Santa Cruz sc-7292×) or 5 μg of antibodies against the analysed
histone modifications (anti-H3K4me3, Active Motif 39159; anti-H3K27me3,
Abcam ab6002; anti-H3K9me3, Abcam ab8898; anti-Suz12, Cell Signaling, #3737).
The pathology tissue chromatin-immunoprecipitation (PAT-ChIP) procedure
was carried out as previously described69. In brief, paraffin was removed with fresh
Histolemon solution (Carlo Erba), chromatin extracted, sonicated and
immunoprecipitated. For the immunoprecipitation step 3 µg of ChIP-grade
antibody was added to 0.5–2.5 µg of tissue chromatin.
Quantitative PCR was performed in triplicate using SYBR Select Master Mix
(ThermoFisher Scientific). Ct values were calculated using ViiaTM 7 software and
relative enrichment was calculated as ChIP/input ratio. Primer sequences are listed
in the Supplementary Table 6.
3D-FISH. In-situ hybridization was essentially as previously described, with minor
modifications70,71. Slides were scored under an Olympus FV-1000 confocal laser-
scanning microscope with a ×100 oil immersion objective using a ×2 optical zoom
with a z-step of 0.3 μm between optical slices as previously described47.
Statistics. Statistical significance was determined with GraphPad Prism 6.0 soft-
ware using unpaired two-tailed t-test (homoscedastic or heteroscedastic where
appropriate) for the analysis of two groups or ANOVA for experiments with two
between-subjects factors (two-way). Bonferroni’s highly significant difference
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(HSD) post hoc analysis was used for multiple pairwise comparison. Data are
presented as mean ± standard deviation (SD) of at least 3 independent experiments,
unless otherwise noted. Differences between data sets were considered significant at
p < 0.05. NS represents no significant difference. Statistical parameters are reported
in the respective figures and figure legends.
For electrophysiological analyses, the number of samples refers to independent
experiments. Assessment of normality of the data was calculated with
Kolmogorov–Smirnov (K–S) test.
Human studies. All human samples were collected after written informed consent
by the patients and the study was approved by the review boards of three clinical
entities: Humanitas Research Hospital (ID:1215), Verona AOUI University Hos-
pital (ID:765cesc), and Ospedali Riuniti di Trieste (ID: 74/2015).
Animal studies. Animal experiments were limited to the teratoma formation assay
to assess pluripotency of the generated iPSC lines and were performed in com-
pliance with the national and EU guidelines for the care and use of laboratory
animals. For the teratoma formation assay, six-week-old NOD:SCID mice (Charles
River Laboratories) were used. The procedure was approved by the Italian Ministry
of Health (137/2012-B).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data that support the findings described in this study are available within the
manuscript and the related supplementary information, and from the corresponding
authors upon request. The source data underlying Figs. 1a–f, 2a–c, 3d, 4b, 7b and 7d,
8b–d, 9c-e and Supplementary Figs. 4D, 6, 7B–D, 12C–E and 13B–E are provided as a
Source Data file.
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